RIGONI, MICOL MARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.981
EU - Europa 1.067
AS - Asia 677
AF - Africa 35
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 5
Totale 3.790
Nazione #
US - Stati Uniti d'America 1.957
CN - Cina 389
SE - Svezia 186
SG - Singapore 170
AT - Austria 162
IT - Italia 120
IE - Irlanda 119
UA - Ucraina 105
FR - Francia 93
DE - Germania 77
FI - Finlandia 73
KR - Corea 42
PL - Polonia 37
SN - Senegal 29
GB - Regno Unito 24
CA - Canada 23
VN - Vietnam 17
IN - India 16
NL - Olanda 16
RU - Federazione Russa 14
AU - Australia 12
BY - Bielorussia 11
EU - Europa 11
UZ - Uzbekistan 10
HK - Hong Kong 8
ES - Italia 7
ID - Indonesia 7
BE - Belgio 6
JP - Giappone 6
CH - Svizzera 3
DK - Danimarca 3
TW - Taiwan 3
ZA - Sudafrica 3
AR - Argentina 2
CZ - Repubblica Ceca 2
GR - Grecia 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
RO - Romania 2
SA - Arabia Saudita 2
BW - Botswana 1
CO - Colombia 1
EG - Egitto 1
IR - Iran 1
JO - Giordania 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
MX - Messico 1
PE - Perù 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TR - Turchia 1
UY - Uruguay 1
Totale 3.790
Città #
Chandler 290
Beijing 274
Vienna 162
Santa Clara 157
Singapore 137
Dublin 116
Ashburn 107
Jacksonville 96
Ann Arbor 90
Fairfield 77
Nyköping 77
Dearborn 67
Houston 65
Villeurbanne 45
Wilmington 45
Medford 44
Woodbridge 42
Princeton 40
Seattle 38
Columbus 35
San Mateo 35
Fremont 34
Warsaw 32
Torino 31
Washington 22
Redwood City 20
Cambridge 19
Pisa 16
Hefei 14
Toronto 14
Guangzhou 12
Boardman 10
Düsseldorf 10
Munich 10
Boston 9
Nanjing 8
New York 8
Phoenix 8
Rotterdam 8
Dong Ket 7
Jakarta 7
Milan 7
Norwalk 7
Paris 7
Provo 7
Brussels 6
Helsinki 6
San Jose 6
Shanghai 6
Chengdu 5
Liverpool 5
Nanchang 5
Philadelphia 5
Volpago Del Montello 5
Changchun 4
Changsha 4
Jinan 4
Los Angeles 4
Piemonte 4
Turin 4
Adelaide 3
Brisbane 3
Central District 3
Dallas 3
Des Moines 3
Hangzhou 3
Hebei 3
Heidelberg 3
Hong Kong 3
Johannesburg 3
Kunming 3
Limoges 3
Mountain View 3
Taipei 3
Tianjin 3
Tokyo 3
Appiano Gentile 2
Bucharest 2
Central 2
Costa Mesa 2
Curcuris 2
Falls Church 2
Fuzhou 2
Grugliasco 2
Göteborg 2
Jaipur 2
Kingston 2
Los Corrales de Buelna 2
Madrid 2
Melbourne 2
Montreal 2
Mortara 2
New Delhi 2
New Haven 2
Ottawa 2
Palermo 2
Pune 2
Québec 2
Raritan 2
Rome 2
Totale 2.535
Nome #
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells 282
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma 201
Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized doubleblind placebo-controlled study 199
Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells 162
The Mevalonate Pathway and Downstream Signal Transducers As Therapeutic Targets to Overcome Multidrug Resistance in Chronic Lymphocytic Leukemia (CLL) 132
Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA) 132
Immunoglobulin variable heavy-chain (Ig Vh) mutational status and tumor microenvironment interactions in B-cell chronic lymphocytic leukaemia 132
Effective anti-tumor immunomodulatory properties of zoledronic acid 127
IDENTIFICATION BY SEROLOGICAL PROTEOME ANALYSIS (SERPA) OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 117
The Mevalonate Pathway As a Metabolic Target to Circumvent Multidrug-Resistance in Chronic Lymphocytic Leukemia Cells 113
THE LOCAL MICROENVIRONMENT PLAYS A DIFFERENT ROLE IN THE SURVIVAL OF TUMOR CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH MUTATED AND UNMUTATED IMMUNOGLOBULIN (IG) VH GENES 110
Role of PD-1/PD-L1 axis in the immune paresis of bone marrow Vγ9Vδ2 T cells in multiple myeloma 109
Identification and functional characterization of tumor specific antibody responses in chronic lymphocytic leukemia 109
IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF ANTIBODY IMMUNE RESPONSES ELICITED BY SELF ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKEMIA 106
IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS 105
Targeting the mevalonate pathway and downstream signaling pathways as a strategy to circumvent multidrug-resistance in CLL cells 104
Serological Proteome Analysis (SERPA) as a tool for the identification of novel tumor antigens in chronic lymphocytic leukemia (CLL) 104
Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cells 103
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells 98
IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals 96
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THE IDENTIFICATION OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY-RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA 95
Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis 94
Identification by serological proteome analysis (SERPA) of tumor-associated antigens eliciting antibody-responses in chronic lymphocytic leukemia 94
Identification by serological proteome analysis (SERPA) of novel tumor associated antigens in chronic lymphocytic leukemia (CLL) 91
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells. 87
The CXCR4 downstream signaling pathways in chronic lymphocytic leukemia: a target to reverse microenvironment protection 83
THE SURVIVAL OF TUMOR CELLS IN IGVH UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA IS HIGHLY DEPENDENT ON EXOGENOUS SIGNALS DELIVERED BY THE TUMOR MICROENVIRONMENT 82
TARGETING THE CXCR4 DOWNSTREAM SIGNALLING PATHWAYS TO REVERSE MICROENVIRONMENT PROTECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 81
null 80
The Mevalonate Metabolic Pathway and the CXCL12/CXCR4 Axis Reciprocally Interact and Are Implicated in Fludarabine Resistance of Chronic Lymphocytic Leukemia Cells 79
The association of dexamethasone + simvastatin to overcome environment-mediated chemoresistance of chronic lymphocytic leukemia (CLL) cells 75
SEROLOGICAL PROTEOME ANALYSIS (SERPA) FOR THEIDENTIFICATION OF NOVEL TUMOR-ASSOCIATED ANTIGENS INCHRONIC LYMPHOCYTIC LEUKEMIA 73
IGHV UNMUTATED CLL B CELLS ARE MORE PRONE TO SPONTANEOUS APOPTOSIS AND DEPEND FROM THE ANTI-APOPTOTIC EFFECT OF ENVIRONMENTAL SIGNALS 73
TARGETING HIF-1 AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER TUMOR-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 71
TARGETING HIF-1A AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER LEUKEMIA-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 69
The mevalonate pathway as a metabolic target to circumvent multidrug-resistance in chronic lymphocytic leukemia cells (CLL) 40
Totale 3.908
Categoria #
all - tutte 10.581
article - articoli 0
book - libri 0
conference - conferenze 8.539
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020313 0 0 0 0 0 76 65 26 19 54 32 41
2020/2021478 54 38 17 15 64 20 17 34 38 20 108 53
2021/2022540 22 3 6 40 28 8 82 35 7 63 166 80
2022/2023696 65 77 17 86 62 166 38 48 69 25 28 15
2023/2024296 38 57 28 10 18 57 6 34 1 6 11 30
2024/2025416 0 25 32 74 284 1 0 0 0 0 0 0
Totale 3.908